Zimmer Biomet 上调 2026 年经调整后每股收益指引至 8.47-8.59 美元，同时将有机营收增长预期提升至 2.25%-3.25% (NYSE:ZBH)
· seekingalpha.com
Zimmer Biomet (ZBH) 2026 年第二季度财报电话会议回顾：销售与技术优势、上调营收/EPS 指引、定价及中国市场风险。
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...